# Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease

> **NCT07563491** · NA · COMPLETED · sponsor: **Muhammad Aamir Latif** · enrollment: 824 (actual)

## Conditions studied

- Gastro Esophageal Reflux

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Vonoprazan

## Key facts

- **NCT ID:** NCT07563491
- **Lead sponsor:** Muhammad Aamir Latif
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 824 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07563491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07563491, "Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07563491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*